In Depth 14 Sep 2022 Rivaling the Golden Triangle at Bristol’s Science Creates hub The Golden Triangle region hosts much of the U.K.’s biotech innovation. However, there are many hubs emerging across the nation, with Bristol’s Science Creates network being one thriving example. The U.K. hosts one of Europe’s leading biotech industries in terms of startup formation, scientific publications and investments. “The U.K. punches well above its weight with […] September 14, 2022 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 7 Sep 2022 The biggest private biotech investments in August 2022 The healthcare-focused companies Orna Therapeutics, F2G and Sironax bagged the biggest biotech investments in August 2022, with mRNA vaccines, genomics and fermentation technology attracting big funding rounds. As many took a well-deserved vacation in the month of August 2022, the world of biotech remained busy with fundraising. Sit back and browse our lists of the […] September 7, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 30 Aug 2022 Biotech incubators scramble to tackle lab space crunch Biotech startups are finding it hard to source lab space in London. Incubators such as Scale Space in the White City hub aim to ease up the pressure by opening flexible lab leases in the city. The COVID-19 pandemic has hammered home the importance of biotechnology in society. As a result, the last few years […] August 30, 2022 - 9 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 24 Aug 2022 To reach Mars, we need biotechnology As we prepare for long-distance space travel and life on Mars, biotechnology will be essential to make spaceships no longer dependent on Earth’s constant supply. “As human beings, we need a constant supply of oxygen. We need constant access to nutritious food, clean water and a safe and clean waste disposal system,” says Italian astronaut […] August 24, 2022 - 11 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 23 Aug 2022 Company’s 3D microchip gives mechanistic insights into human brain A microchip that allows scientists to study the complexity of 3D cellular networks at unrivaled scale and precision has been added to 3Brain AG’s brain-on-chip portfolio. In collaboration with Swiss precision manufacturing experts, CSEM, 3Brain AG made the announcement today (August 22). The cell-electronic interface technology will also allow scientists to gain novel mechanistic insights […] August 23, 2022 - 5 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
In Depth 18 Aug 2022 How technology transfer offices can navigate biotech commercialization Technology transfer offices are vital departments for commercializing an academic’s biotech innovations, yet they can also be resource-stretched and averse to risk. Here are some ways they can streamline their process and land more deals with investors and big pharma. Technology transfer offices (TTOs) perform vital functions in universities by guiding academics through the process […] August 18, 2022 - 8 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 15 Aug 2022 Can phage therapy answer the booming antibiotic resistance problem? Antibiotic-resistant superbugs cause a large number of deaths around the world each year, but effective new antibiotics are thin on the ground. Could bacteria-eating phage viruses be the answer to this problem? The COVID-19 pandemic has received blanket news coverage over the past couple of years, however, it still pales in comparison to the threat […] August 15, 2022 - 8 minutesmins - By David Cox Share WhatsApp Twitter Linkedin Email
In Depth 11 Aug 2022 Biosecurity is synthetic biology’s most crucial ally Synthetic biology has made it easier than ever to engineer organisms to serve our needs. But as the technology becomes widespread, concerns about its potential misuse arise. How can we ensure biosecurity without hindering the advance of synthetic biology? Biosecurity consists of the prevention of and response to the release of potentially harmful organisms. Now […] August 11, 2022 - 6 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
In Depth 4 Aug 2022 The biggest Asia-Pacific biotech investments in July 2022 China’s vaccine developer MaxHealth Biotechnology raised the biggest private biotech investment in the Asia-Pacific region in July 2022, followed by China Immunotech and Ruibo Bio. MaxHealth Biotechnology reigned supreme in the Asia-Pacific region’s private biotech investment sphere in July 2022, with a $74 million Series B round. The company will use the money to fuel […] August 4, 2022 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 3 Aug 2022 The biggest European biotech investments in July 2022 The mRNA firm Normax Biomed snagged Europe’s biggest private biotech investment in July 2022, with runners-up including AgomAb and Tropic Biosciences. Life sciences manufacturing companies saw a big windfall in Europe in July 2022 as the Cork-based Normax Biomed bagged around $301 million. The firm is establishing modular manufacturing facilities that could provide mRNA vaccines […] August 3, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 2 Aug 2022 The evolving arsenal against mosquito-borne diseases Genetic engineering is breaking new ground in the control of mosquito-borne diseases. However, a genetic engineering approach isn’t the only option, as many biotech companies aim to prove. As the global climate continues to warm, disease-spreading mosquitoes such as Aedes aegypti are expected to establish themselves in the U.S. and Europe. This could result in […] August 2, 2022 - 8 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 1 Aug 2022 The biggest US biotech investments in July 2022 The asthma specialist Areteia Therapeutics took the U.S.’ top private biotech investment crown in July 2022, with runners-up including liquid biopsy firm Delfi Diagnostics and the metabolic disease drug developer Carmot Therapeutics. The U.S.’ top private biotech investments in July 2022 didn’t reach the giddy heights of National Resilience’s $625 million Series D round in […] August 1, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email